Gryaznov Sergei 4
4 · MAIA Biotechnology, Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Award
Stock Options
2025-05-14+200,000→ 200,000 totalExercise: $1.76Exp: 2035-05-14→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.